J. Chas

All-oral Direct-acting Antiviral Regimens in HIV/Hepatitis C Virus–coinfected Patients With Cirrhosis Are Efficient and Safe: Real-life Results From the Prospective ANRS CO13–HEPAVIH Cohort

Philippe Sogni, Camille Gilbert, Karine Lacombe et al. · Clinical Infectious Diseases · 2016 · 60 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Efficacy and safety of direct-acting antiviral regimens in HIV/HCV-co-infected patients – French ANRS CO13 HEPAVIH cohort

Lionel Piroth, Linda Wittkop, Karine Lacombe et al. · Journal of Hepatology · 2017 · 48 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +12

Increased mortality in HIV/HCV-coinfected compared to HCV-monoinfected patients in the DAA era due to non-liver-related death

Mathieu Chalouni, Stanislas Pol, Philippe Sogni et al. · Journal of Hepatology · 2020 · 35 citations

Veterinary Medicine, Infectious Diseases, Epidemiology +10

Real-World Efficacy of Daclatasvir and Sofosbuvir, With and Without Ribavirin, in HIV/HCV Coinfected Patients With Advanced Liver Disease in a French Early Access Cohort

Karine Lacombe, Hélène Fontaine, Catherine Dhiver et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2017 · 34 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Daily cannabis and reduced risk of steatosis in human immunodeficiency virus and hepatitis C virus‐co‐infected patients (<scp>ANRS CO</scp>13‐<scp>HEPAVIH</scp>)

Sandra Nordmann, Antoine Vilotitch, Perrine Roux et al. · Journal of Viral Hepatitis · 2017 · 28 citations

Medicine, Health Behavior, Clinical Epidemiology +12